Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Res Cardiol ; 112(4): 455-463, 2023 Apr.
Article in English | MEDLINE | ID: mdl-35729429

ABSTRACT

BACKGROUND: In Germany, 70,000-100,000 persons per year suffer from out-of-hospital cardiac arrest (OHCA). Despite medical progress, survival rates with good neurological outcome remain low. For many important clinical issues, no or only insufficient evidence from randomised trials is available. Therefore, a systemic and standardised acquisition of the treatment course and of the outcome of OHCA patients is warranted. STUDY DESIGN: The German Cardiac Arrest Registry (G-CAR) is an observational, prospective, multicentre registry. It will determine the characteristics, initial treatment strategies, invasive procedures, revascularisation therapies and the use of mechanical circulatory support devices with a focus on extracorporeal cardiopulmonary resuscitation. A special feature is the prospective 12-month follow-up evaluating mortality, neurological outcomes and several patient-reported outcomes in the psychosocial domain (health-related quality of life, cognitive impairment, depression/anxiety, post-traumatic stress disorder and social reintegration). In a pilot phase of 24 months, 15 centres will include approximately 400 consecutive OHCA patients ≥ 18 years. Parallel to and after the pilot phase, scaling up of G-CAR to a national level is envisaged. CONCLUSION: G-CAR is the first national registry including a long-term follow-up for adult OHCA patients. Primary aim is a better understanding of the determinants of acute and long-term outcomes with the perspective of an optimised treatment. TRIAL REGISTRY: NCT05142124. German Cardiac Arrest Registry (G-CAR).


Subject(s)
Cardiopulmonary Resuscitation , Extracorporeal Membrane Oxygenation , Out-of-Hospital Cardiac Arrest , Adult , Humans , Prospective Studies , Treatment Outcome , Quality of Life , Extracorporeal Membrane Oxygenation/methods , Cardiopulmonary Resuscitation/methods , Out-of-Hospital Cardiac Arrest/therapy , Registries
2.
Stroke ; 52(5): e117-e130, 2021 05.
Article in English | MEDLINE | ID: mdl-33878892
3.
Microorganisms ; 8(2)2020 Jan 25.
Article in English | MEDLINE | ID: mdl-31991721

ABSTRACT

In this study the response of biogas-producing microbiomes to a profound feedstock change was investigated. The microbiomes were adapted to the digestion of either 100% sugar beet, maize silage, or of the silages with elevated amounts of total ammonium nitrogen (TAN) by adding ammonium carbonate or animal manure. The feedstock exchange resulted in a short-range decrease or increase in the biogas yields according to the level of chemical feedstock complexity. Fifteen taxa were found in all reactors and can be considered as generalists. Thirteen taxa were detected in the reactors operated with low TAN and six in the reactors with high TAN concentration. Taxa assigned to the phylum Bacteroidetes and to the order Spirochaetales increased with the exchange to sugar beet silage, indicating an affinity to easily degradable compounds. The recorded TAN-sensitive taxa (phylum Cloacimonetes) showed no specific affinity to maize or sugar beet silage. The archaeal community remained unchanged. The reported findings showed a smooth adaptation of the microbial communities, without a profound negative impact on the overall biogas production indicating that the two feedstocks, sugar beet and maize silage, potentially do not contain chemical compounds that are difficult to handle during anaerobic digestion.

4.
Anaerobe ; 56: 8-16, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30633970

ABSTRACT

To investigate whether there is a nexus between the microbial diversity level (taxonomic, functional and ecological) and the stress tolerance potential of the microbial community, the impact of different ammonium sources was evaluated. Therefore reactors adapted either to the anaerobic digestions of sugar beet silage or maize silage (SBS/MS) were supplemented with animal manure (M) or ammonium carbonate (A). The results showed that increasing concentrations of total ammonium nitrogen (TAN) were not the only reason for community changes: the bacterial community in the reactors given animal manure became more similar over time compared to the reactors given ammonium carbonate. However, this study revealed that a bacterial community with a few dominant members led to a functional more flexible archaeal community (SBS reactors) which was more stress resistant under the experimental conditions. This indicates that a higher functional diversity within a certain part of the community, in the present study the archaeal community, is one important factor for process stability due to a higher tolerance to increasing amounts of process-inhibiting metabolites such as TAN. Compared to this a bacterial community with higher amount of more evenly distributed community members combined with a more rigid archaeal community (MS reactors) showed a lower stress tolerance potential. Moreover it was observed that the disappearance of members of the phylum Cloacimonetes can be used as an indicator for an upcoming process disturbance due to increasing TAN concentrations.


Subject(s)
Ammonium Compounds/metabolism , Archaea/metabolism , Bacteria/metabolism , Biofuels/microbiology , Biota , Manure/microbiology , Stress, Physiological , Anaerobiosis , Animals , Archaea/growth & development , Bacteria/growth & development , Beta vulgaris/metabolism , Culture Media/chemistry , Zea mays/metabolism
5.
Pulm Pharmacol Ther ; 26(2): 265-70, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23257347

ABSTRACT

Selectins, a family of cell adhesion molecules, are involved in leukocyte extravasation to sites of inflammation. We investigated the safety and efficacy of the inhaled pan-selectin antagonist Bimosiamose in patients with chronic obstructive pulmonary disease (COPD). 77 COPD patients (mean forced expiratory volume in 1 s, 57% pred.) were enrolled in a cross-over, double-blind, randomized, Placebo-controlled, multi-center trial. Bimosiamose (10 mg) or Placebo was inhaled twice daily via the breath actuated nebulizer Akita2 Apixneb™ for 28 days on top of standard bronchodilator therapy. Efficacy was assessed by measurement of inflammatory parameters in induced sputum (differential cell count, interleukin-8, matrix-metalloproteinase-9, myeloperoxidase) and lung function at day 28 of both treatment periods. The total adverse event ratio of Bimosiamose compared to Placebo treatment was balanced. Compared to Placebo, treatment with Bimosiamose led to a decrease of the interleukin-8 concentration (-9.49 ng/mL, 95%CI -18.8 to -2.7 ng/mL, p = 0.008), for the neutrophil count a difference of -0.368 × 10(6) cells/mL (95%CI -1.256 to 0.407 × 10(6)/mL, p = 0.313) was found. The macrophage count decreased by -0.200 × 10(6) cells/mL (95%CI -0.365 to -0.044 × 10(6) cells/mL, p = 0.012). Most lung function parameters showed a small numeric increase. Inhalation of Bimosiamose for 28 days was safe and well tolerated in patients with COPD. It led to an attenuation of airway inflammation (EudraCT 2009-017257-35; NCT ID: NCT01108913).


Subject(s)
Asthma/drug therapy , Hexanes/therapeutic use , Mannose/analogs & derivatives , Pulmonary Disease, Chronic Obstructive/drug therapy , Selectins/physiology , Administration, Inhalation , Aged , Cross-Over Studies , Double-Blind Method , Female , Hexanes/administration & dosage , Hexanes/adverse effects , Humans , Interleukin-8/analysis , Male , Mannose/administration & dosage , Mannose/adverse effects , Mannose/therapeutic use , Matrix Metalloproteinase 9/analysis , Middle Aged
6.
Pulm Pharmacol Ther ; 24(5): 555-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21514398

ABSTRACT

Selectins, a family of cell adhesion molecules, are involved in the activation and extravasation of leukocytes in inflammatory diseases. Inhalation of ozone induces an inflammation of the airways, which is dominated by neutrophils. We investigated the effect of repeated inhalations of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy volunteers. In a double-blind, placebo-controlled, randomized, cross-over study Bimosiamose (10 mg bid) was inhaled via a breath actuated nebulizer (AKITA2 APIXNEB(®)) for 4 days. Treatment was followed by inhalation of ozone (250 ppb) for 3 h with intermittent exercise. Induced sputum was collected 3 h post ozone challenge for analysis of cellular and non-cellular composition. 18 subjects were randomized and completed the study. All treatments were safe and well tolerated. Compared to placebo Bimosiamose reduced the numbers of sputum neutrophils by 40% (p = 0.068) and concentrations of interleukin-8 and matrix-metalloproteinase-9 in sputum supernatant by 35% (p = 0.004) and 46% (p = 0.022), respectively. Inhalation of Bimosiamose showed favourable anti-inflammatory effects on ozone-induced airway inflammation in healthy volunteers. Further studies have to proof and translate this anti-inflammatory effect of Bimosiamose into a clinical benefit in patients with chronic obstructive pulmonary disease. (ClinTrialgov Ident: NCT01108913).


Subject(s)
Hexanes/pharmacology , Inflammation/drug therapy , Mannose/analogs & derivatives , Ozone/adverse effects , Respiratory System/drug effects , Adult , Cross-Over Studies , Double-Blind Method , Exercise Test , Female , Hexanes/adverse effects , Humans , Inflammation/etiology , Inhalation Exposure , Interleukin-8/drug effects , Interleukin-8/metabolism , Male , Mannose/adverse effects , Mannose/pharmacology , Matrix Metalloproteinase 9/drug effects , Matrix Metalloproteinase 9/metabolism , Middle Aged , Nebulizers and Vaporizers , Neutrophils/immunology , Respiratory System/pathology , Sputum/immunology
7.
J Med Chem ; 50(6): 1101-15, 2007 Mar 22.
Article in English | MEDLINE | ID: mdl-17302397

ABSTRACT

This report describes the first results of a rational hit-finding strategy to design novel small molecule antiinflammatory drugs targeting selectins, a family of three cellular adhesion molecules. Based on recent progress in understanding of molecular interaction between selectins and their natural ligands as well as progress in clinical development of synthetic antagonists like 1 (bimosiamose, TBC1269), this study was initiated to discover small molecule selectin antagonists with improved pharmacological properties. Considering 1 as template structure, a ligand-based approach followed by focused chemical synthesis has been applied to yield novel synthetic small molecules (MWr < 500) with a trihydroxybenzene motif, bearing neither peptidic nor glycosidic components, with nanomolar in vitro activity. Biological evaluation involves two kinds of in vitro assays, a static molecular binding assay, and a dynamic HL-60 cell attachment assay. As compared to controls, the novel compounds showed improved biological in vitro activity both under static and dynamic conditions.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Hexanes/chemistry , Mannose/analogs & derivatives , Phenols/chemical synthesis , Selectins/metabolism , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Binding, Competitive , Cell Adhesion , Drug Design , E-Selectin/metabolism , HL-60 Cells , Humans , L-Selectin/metabolism , Ligands , Mannose/chemistry , Models, Molecular , P-Selectin/metabolism , Phenols/chemistry , Phenols/pharmacology , Protein Binding
8.
Expert Opin Investig Drugs ; 15(8): 963-79, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16859397

ABSTRACT

Psoriasis is a systemic chronic inflammatory disorder. One of the major characteristics is an excess of infiltration of inflammatory cells, mainly lymphocytes, into the skin. Because the adhesion family of selectins is suggested to play a relevant role in this process, selectins have emerged as an interesting target for drug discovery and development in psoriasis. Different strategies targeting selectins have been described. This review discusses these approaches and summarises the current development of selectin antagonists for the treatment of psoriasis. An expert opinion will give the authors' personal opinion about selectin antagonism in psoriasis and which approach might be preferable.


Subject(s)
Dermatologic Agents/therapeutic use , Glycoproteins/metabolism , Leukocytes/drug effects , Protein Processing, Post-Translational/drug effects , Psoriasis/drug therapy , Selectins/drug effects , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Acetylcysteine/therapeutic use , Animals , Dermatologic Agents/pharmacology , Dimethyl Fumarate , Fumarates/pharmacology , Fumarates/therapeutic use , Gene Expression Regulation/drug effects , Glycosphingolipids/pharmacology , Glycosphingolipids/therapeutic use , Glycosylation , Humans , Leukocyte Rolling , Leukocytes/immunology , Ligands , Models, Animal , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Psoriasis/immunology , Psoriasis/metabolism , Randomized Controlled Trials as Topic , Selectins/genetics , Selectins/metabolism
9.
Arch Dermatol Res ; 297(8): 345-51, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16362415

ABSTRACT

The selectin family of vascular cell adhesion molecules is comprised of structurally related carbohydrate binding proteins, which mediate the initial rolling of leukocytes on the activated vascular endothelium. Because this process is one of the crucial events in initiating and maintaining inflammation, selectins are proposed to be an attractive target for the development of new antiinflammatory therapeutics. Here, we demonstrate that the synthetic pan-selectin antagonist bimosiamose is effective in pre-clinical models of psoriasis as well as in psoriatic patients. In vitro bimosiamose proved to be inhibitory to E- or P-selectin dependent lymphocyte adhesion under flow conditions. Using xenogeneic transplantation models, bimosiamose reduced disease severity as well as development of psoriatic plaques in symptomless psoriatic skin. The administration of bimosiamose in patients suffering from psoriasis resulted in a reduction of epidermal thickness and lymphocyte infiltration. The clinical improvement was statistically significant (P=0.02) as analyzed by comparison of psoriasis area and severity index before and after treatment. Assessment of safety parameters showed no abnormal findings. These data suggest that pan-selectin antagonism may be a promising strategy for the treatment of psoriasis and other inflammatory diseases.


Subject(s)
Hexanes/therapeutic use , Mannose/analogs & derivatives , P-Selectin/physiology , Adult , Animals , Anti-Inflammatory Agents/therapeutic use , Cell Adhesion/drug effects , Cell Line , Cell Proliferation/drug effects , Disease Models, Animal , Endothelium, Vascular/pathology , Endothelium, Vascular/physiopathology , Epidermis/chemistry , Epidermis/pathology , Female , HL-60 Cells , Hexanes/blood , Hexanes/pharmacology , Humans , Jurkat Cells , Leukocytes/pathology , Leukocytes/physiology , Male , Mannose/blood , Mannose/pharmacology , Mannose/therapeutic use , Mice , Mice, SCID , Middle Aged , P-Selectin/analysis , Pilot Projects , Psoriasis/blood , Psoriasis/drug therapy , Psoriasis/pathology , Psoriasis/physiopathology , T-Lymphocytes/pathology
10.
Eur J Immunol ; 33(4): 920-7, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12672058

ABSTRACT

The anaphylatoxic peptide C3a is a pro-inflammatory mediator generated during complement activation, whose specific G protein coupled receptor is expressed on granulocytes, monocytes, mast cells, activated lymphocytes, and in the nervous tissue. We have generated RBL-2H3 cell clones stably expressing mutants of the human C3a-receptor (C3aR) with combined alanine (Ala) substitutions of ten C-terminal serine (Ser) or threonine (Thr) residues, which may represent putative phosphorylation sites to characterize their role in ligand-induced C3aR internalization and signaling. Ser475/479 and Thr480/481 as well as Ser449 seemed not to be involved in ligand-induced receptor internalization. Either directly or by a conformational change they even "inhibit" C3aR internalization. In contrast, mutants with Ala substitutions at Ser465/470 and Thr463/466 were poorly internalized, and Thr463 seemed to be the most important C-terminal Thr or Ser residue directly effecting receptor internalization. However, it is likely that other C3aR regions additionally participate in this negative feed-back mechanism since even mutants with multiple Ala substitutions still internalized to a limited degree. Interestingly, in a mutant with a single exchange of Ser449 to Ala, the signal transduction assessed by a Ca(2+) assay and [(35)S]GTP gamma S-binding on HEK cells transiently co-transfected with G-alpha 16 or G-alpha O, respectively, was severely impaired, indicating that this residue of C3aR is involved in G protein coupling.


Subject(s)
Membrane Proteins , Receptors, Complement/chemistry , Receptors, Complement/physiology , Serine/physiology , Signal Transduction , Threonine/physiology , Animals , Calcium/metabolism , Cell Line , Endocytosis , GTP-Binding Protein alpha Subunits , GTP-Binding Protein alpha Subunits, Gq-G11 , Heterotrimeric GTP-Binding Proteins/metabolism , Humans , Kinetics , Mutation , Rats , Receptors, Complement/genetics , Serine/genetics , Structure-Activity Relationship , Threonine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...